Skip to main content
Message Font: Serif | Sans-Serif
No. of Recommendations: 0
PALO ALTO, Calif., and CLEVELAND, July 9 /PRNewswire/ -- Incyte Genomics, Inc. INCY, the leading genomic information company, and Secant Technologies, a leading infrastructure software company, today announced a strategic partnership to market and further develop Incyte's Genomics Knowledge Platform (GKP), a software environment that represents a major breakthrough for life science researchers. Incyte will continue to market the Genomics Knowledge Platform to the life science community and support its existing customer base. In addition, the partnership provides Secant with an exclusive license to assume further development and marketing of the GKP and for Incyte to make an equity investment in Secant. The companies will also collaborate on professional services and support offerings for GKP customers. Financial terms were not disclosed.

Development of Incyte's Genomics Knowledge Platform to date, has been the result of a significant collaboration with Secant Technologies over the past twenty months. Incyte and Secant have combined advances in both scientific research and high-performance enterprise computing. The Genomics Knowledge Platform allows life sciences researchers to integrate and analyze a variety of data types, including gene sequence, expression, polymorphism, and proteomic data, as well as functional data.

"We constructed the Genomics Knowledge Platform to extend data integration beyond genomics to all science-based information types, including chemical and clinical. It's only natural, therefore, that the universal open architecture which allows for collaboration with other information providers and software creators can be better served by a company like Secant whose focus is software and data integration," said Roy A. Whitfield, Chief Executive Officer of Incyte. "Under the licensing agreement, Incyte will continue to market this e-research platform with our content to the life sciences community and our existing customer base."

"We are excited about the market opportunity that lies ahead as a result of exclusively licensing the Genomics Knowledge Platform (GKP) from Incyte. This allows us to further develop the platform with our Model-Driven Infrastructure(TM) and SmartFarm(TM) parallel processing technologies, position the platform as an industry standard, and provide vertical solutions to additional markets that are not currently served by Incyte," said Jim Holt, President of Secant Technologies.

The Genomics Knowledge Platform will continue to provide Incyte with the framework for its next generation of information products.

About Secant Technologies

Secant Technologies, Inc. provides model-driven infrastructure software that ensures the performance and scalability of the most complex and demanding applications. Software platforms powered by Secant have achieved high rate of success for companies like i2 Technologies and Open Telecommunications and will help to guarantee the success of the Genomics Knowledge Platform. Secant provides the power to perform.

Secant has won awards from Network Computing and Java Developer's Journal, a Crossroads 2001 A-List Award and more. For more information, visit Secant's Web site at or call 888-473-2268.

Print the post  


What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.